These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12142632)
1. Extremely prolonged elimination of cibenzoline at toxic plasma concentrations in patients with renal impairments. Takahashi M; Echizen H; Takahashi K; Shimada S; Aoyama N; Izumi T Ther Drug Monit; 2002 Aug; 24(4):492-6. PubMed ID: 12142632 [TBL] [Abstract][Full Text] [Related]
2. [A case of acute cibenzoline intoxication in a hemodialysis patient]. Ozasa Y; Takamura S; Seishi I; Kitada H; Uekihara S; Hayano S Chudoku Kenkyu; 2003 Jul; 16(3):335-8. PubMed ID: 14582357 [TBL] [Abstract][Full Text] [Related]
3. Effect of renal impairment on the pharmacokinetics of cibenzoline. Massarella JW; Khoo KC; Aogaichi K; Di Persio D; Smith M; Kluger J; Chow MS Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622 [TBL] [Abstract][Full Text] [Related]
4. Effect of charcoal hemoperfusion on clearance of cibenzoline succinate (cifenline) poisoning. Aoyama N; Sasaki T; Yoshida M; Suzuki K; Matsuyama K; Aizaki T; Izumi T; Kondo R; Kamijo Y; Soma K; Ohwada T J Toxicol Clin Toxicol; 1999; 37(4):505-8. PubMed ID: 10465249 [TBL] [Abstract][Full Text] [Related]
5. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance. Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cibenzoline in patients with renal impairment. Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200 [TBL] [Abstract][Full Text] [Related]
7. Heart failure elevates serum levels of cibenzoline in arrhythmic patients. Kotake T; Takada M; Komamura K; Kamakura S; Miyatake K; Kitakaze M; Morishita H Circ J; 2006 May; 70(5):588-92. PubMed ID: 16636495 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function. Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527 [TBL] [Abstract][Full Text] [Related]
12. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers. Khoo KC; Givens SV; Parsonnet M; Massarella JW J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991 [TBL] [Abstract][Full Text] [Related]
13. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline. Canal M; Flouvat B; Tremblay D; Dufour A Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865 [TBL] [Abstract][Full Text] [Related]
15. Cibenzoline intoxication necessitating implantation of a biventricular assist system in a patient with severe cardiomyopathy. Ohata T; Ueda H; Yamada Y Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):95-7. PubMed ID: 20421279 [TBL] [Abstract][Full Text] [Related]